• ZK53: Human Mitochondrial Serine Protease ClpP Activator in

  2026-07-08

  ZK53 is a breakthrough human mitochondrial serine protease ClpP activator, tailored for precision disruption of mitochondrial metabolism in tumor cells. Its selectivity and robust in vivo tolerability make it an essential tool for dissecting mitochondrial vulnerabilities and integrating metabolic interventions in advanced cancer research.

• Carbapenemase Gene Mobility in CREC: Guangdong Hospitals 202

  2026-07-07

  The referenced study systematically characterized carbapenemase-encoding gene (CEG) prevalence and transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight Guangdong hospitals during the COVID-19 pandemic. High rates of multidrug resistance and plasmid-mediated gene transfer were observed, highlighting urgent challenges for infection control and antimicrobial resistance research.

• SIRT1/2 Inhibitor IV (cambinol): Applied Workflows for CNS &

  2026-07-07

  SIRT1/2 Inhibitor IV (cambinol) empowers researchers to dissect metabolic-epigenetic crosstalk in CNS injury and oncology models, offering precise control over SIRT1- and SIRT2-dependent pathways. This article delivers advanced protocols and troubleshooting strategies, leveraging new mechanistic insights into non-histone lactylation and astrocyte polarization.

• Melittin: Mechanistic Insights and Assay Impact in Signal Tr

  2026-07-06

  Explore how Melittin, a potent bioactive peptide, uniquely modulates G protein signaling to advance apoptosis and cancer biology research. This article delivers a deeper, mechanism-focused perspective—illuminating practical decisions for assay design and data interpretation.

• Alda 1: Advanced ALDH2 Activator for Cardiac Ischemia Resear

  2026-07-06

  Alda 1 from APExBIO stands out as a potent ALDH2 activator, enabling researchers to model cardioprotection and aldehyde detoxification in both wild-type and mutant backgrounds. This article translates breakthrough evidence on cardiomyocyte proliferation and experimental optimization into actionable protocols for cardiac ischemia and radiation-induced dermatitis research.

• 5-HT3 Antagonists Modulate Renal OCT2/MATE1: In Vitro Insigh

  2026-07-05

  This study systematically evaluates how five antiemetic 5-HT3 receptor antagonists, including tropisetron, inhibit renal organic cation transporters OCT2 and MATE1 in vitro. The findings reveal differential transporter inhibition, with implications for drug-drug interactions and pharmacokinetics in serotonin receptor signaling research.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-07-04

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system in hypertension and renal studies. It is designed for protocols focused on blood pressure regulation and aldosterone signaling, but should not be used outside cardiovascular or renal research contexts due to its specific biochemical and solubility properties.

• Regorafenib Suppresses Melanoma via RRM2 and ERK/E2F3 Pathwa

  2026-07-03

  Recent research uncovers that Regorafenib (BAY 73-4506) exerts potent antitumor effects in melanoma by targeting RRM2 and the ERK/E2F3 signaling pathway. These findings highlight a mechanistic advance and suggest new experimental routes for cancer biology research targeting tumor progression and metastasis.

• 4-Hydroxytamoxifen: Technical Workflow Guide for Lab Researc

  2026-07-03

  4-Hydroxytamoxifen addresses the need for a high-purity, DMSO-soluble estrogen receptor modulator in precise research settings, especially in breast and prostate cancer studies and cardiac myocyte assays. It is not compatible with ethanol or aqueous-based protocols, and correct storage and handling are critical to maintain reproducibility.

• BGJ398 (NVP-BGJ398): Optimizing FGFR Signaling Research Work

  2026-07-02

  BGJ398 (NVP-BGJ398) empowers oncology and developmental biology labs to precisely dissect FGFR signaling, with proven potency and selectivity in both cancer and morphogenesis models. This guide delivers protocol-driven enhancements, troubleshooting strategies, and translational assay insights rooted in recent comparative research.

• Stattic and STAT3 Inhibition: Molecular Insights and Transla

  2026-07-02

  Explore how Stattic, a potent STAT3 inhibitor, uniquely advances cancer biology, radiosensitization, and apoptosis induction. This article provides in-depth mechanisms, protocol nuances, and new insights for assay optimization.

• Annexin V, Human Recombinant: Precision Phosphatidylserine B

  2026-07-01

  Explore how Annexin V, a leading phosphatidylserine binding protein, enables nuanced apoptosis assays and innovative cell death investigations. This article delivers deep scientific insights and practical protocols, distinguishing itself with advanced applications and reference-driven guidance.

• O-GlcNAcylation Regulates Ferroptosis and Syncytialization i

  2026-07-01

  This study reveals that O-GlcNAc modification, via stabilization of the E3 ligase HUWE1, orchestrates transferrin receptor 1 (TfR1) degradation, thereby suppressing ferroptosis and rescuing trophoblast syncytialization defects in preeclampsia. The findings clarify a mechanistic link between O-GlcNAcylation, iron homeostasis, and placental pathology, suggesting new therapeutic angles for pregnancy complications.

• BX795: Precision PDK1 Inhibition for Translational Impact

  2026-06-30

  This thought-leadership article explores how BX795, a potent PDK1 inhibitor, enables translational researchers to dissect PI3K/Akt/mTOR and innate immune pathways with unprecedented precision. By integrating mechanistic insights, recent advances in in vitro drug evaluation, and strategic workflow guidance, we illuminate best practices for leveraging BX795 in cancer and immunology research—and chart new territory beyond conventional product pages.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-06-30

  A recent study demonstrates that ALDH2 activation significantly extends the proliferative window of cardiomyocytes and delays the progression of pressure overload-induced heart failure in mice. These findings highlight the therapeutic potential of ALDH2 activators for cardiac regeneration and inform future research on mechanisms of cardioprotection and aldehyde detoxification.

436 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page